Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel.

Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel.

Item
http://www.wikidata.org/entity/Q43225374
Androgen receptor activation in castration-recurrent prostate cancer: the role of Src-family and Ack1 tyrosine kinasesSRC: marker or actor in prostate cancer aggressivenessA randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients.Docetaxel plus oral metronomic cyclophosphamide: a phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients.Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity.Current treatments and novel therapeutic targets for castration resistant prostate cancer with bone metastasisSrc promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures.Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer.Therapeutic modulation of prostate cancer metastasis.Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics.Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models.Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancer.
P2860

Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel.

Item
http://www.wikidata.org/entity/Q43225374
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Long-term use of dasatinib in ...... on of dasatinib and docetaxel.
@en
Long-term use of dasatinib in ...... on of dasatinib and docetaxel.
@nl
type
label
Long-term use of dasatinib in ...... on of dasatinib and docetaxel.
@en
Long-term use of dasatinib in ...... on of dasatinib and docetaxel.
@nl
prefLabel
Long-term use of dasatinib in ...... on of dasatinib and docetaxel.
@en
Long-term use of dasatinib in ...... on of dasatinib and docetaxel.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P932
P356
P1433
P1476
Long-term use of dasatinib in ...... on of dasatinib and docetaxel.
@en
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P932